Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...
Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...
Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...
2h
Cathie Wood Offloads Millions of Biotech Shares, Ramps Stake in Veracyte Days Before Earnings Beat
Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...
Our new but simple method is far more effective and can now be applied to a much wider range of plant species than our ...
Next-Generation Biopharmaceuticals Transforming the Global Therapeutic LandscapeThe Global Bio Pharmaceuticals Market is ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...
Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
Meanwhile, ARK sold 15,362 shares of Roku Inc (NASDAQ:ROKU) through its ARKK ETF, totaling $1,668,774. This marks a continuation of ARK’s recent trend of reducing its holdings in the streaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback